{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:55:12Z","timestamp":1792000512985,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.medj.2025.100724","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T10:34:33Z","timestamp":1749465273000},"page":"100724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7143-7726","authenticated-orcid":false,"given":"Vijay R.","family":"Varma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemek R.","family":"Kac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Bilgel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Moghekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Loeffler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Amschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Daurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Prokesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100724_bib1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","article-title":"Blood biomarkers for Alzheimer's disease in clinical practice and trials","volume":"3","author":"Hansson","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.medj.2025.100724_bib2","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer's disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.medj.2025.100724_bib3","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of Abeta42\/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100724_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-024-00711-1","article-title":"Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting","volume":"19","author":"Zeng","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.medj.2025.100724_bib5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"Plasma Abeta42\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100724_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3233\/ADR-230029","article-title":"Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice","volume":"7","author":"Pais","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.medj.2025.100724_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/alz.12283","article-title":"The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease","volume":"17","author":"Simren","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100724_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","article-title":"Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers","volume":"80","author":"Mattsson-Carlgren","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","article-title":"Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology","volume":"141","author":"Ashton","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.medj.2025.100724_bib11","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1002\/alz.13157","article-title":"Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid","volume":"19","author":"Bilgel","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100724_bib12","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41467-024-46876-7","article-title":"Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology","volume":"15","author":"Kac","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2025.100724_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.medj.2025.100724_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s43587-023-00566-z","article-title":"Blood protein markers predict 15-year risk of dementia","volume":"4","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.medj.2025.100724_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK Biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.medj.2025.100724_bib16","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.51652","article-title":"A population-based meta-analysis of circulating GFAP for cognition and dementia risk","volume":"9","author":"Gonzales","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Lantero Rodriguez","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.medj.2025.100724_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","article-title":"Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration","volume":"7","author":"Ashton","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.medj.2025.100724_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive Astrocytes: Production, Function, and Therapeutic Potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.medj.2025.100724_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.medj.2025.100724_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2021.02.012","article-title":"Astrogliosis and episodic memory in late life: higher GFAP is related to worse memory and white matter microstructure in healthy aging and Alzheimer's disease","volume":"103","author":"Bettcher","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.medj.2025.100724_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","article-title":"Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment","volume":"13","author":"Cicognola","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.medj.2025.100724_bib23","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","article-title":"Astrocyte reactivity influences amyloid-beta effects on tau pathology in preclinical Alzheimer's disease","volume":"29","author":"Bellaver","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2025.100724_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-024-00750-8","article-title":"Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease","volume":"19","author":"Guo","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.medj.2025.100724_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101335","article-title":"Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease","volume":"68","author":"Price","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.medj.2025.100724_bib26","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/glia.23981","article-title":"Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model","volume":"69","author":"Smit","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.medj.2025.100724_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awae035","article-title":"Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles","volume":"147","author":"Sanchez-Juan","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.medj.2025.100724_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12794","article-title":"Visuo-spatial learning and memory impairments in the 5xFAD mouse model of Alzheimer's disease: Effects of age, sex, albinism, and motor impairments","volume":"21","author":"O'Leary","year":"2022","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.medj.2025.100724_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2015.4333","article-title":"Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid beta up to 90 Days after Traumatic Brain Injury","volume":"34","author":"Bogoslovsky","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.medj.2025.100724_bib31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41380-022-01912-0","article-title":"Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease","volume":"28","author":"Varma","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.medj.2025.100724_bib32","article-title":"Heritability of Alzheimer's disease plasma biomarkers: A nuclear twin family design","volume":"21","author":"Rousset","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.medj.2025.100724_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217123","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads","volume":"15","author":"Salvado","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.medj.2025.100724_bib34","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-Head Comparison of 8 Plasma Amyloid-beta 42\/40 Assays in Alzheimer Disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib35","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/gerona\/63.12.1416","article-title":"The Baltimore Longitudinal Study of Aging (BLSA): a 50-year-long journey and plans for the future","volume":"63","author":"Ferrucci","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.medj.2025.100724_bib36","series-title":"Normal Human Aging: The Baltimore Longitudinal Study of Aging","author":"Shock","year":"1984"},{"key":"10.1016\/j.medj.2025.100724_bib37","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1212\/WNL.54.11.2072","article-title":"Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging","volume":"54","author":"Kawas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100724_bib38","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-2009-1179","article-title":"Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA)","volume":"18","author":"O'Brien","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.medj.2025.100724_bib39","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.21413","article-title":"Effect of infarcts on dementia in the Baltimore longitudinal study of aging","volume":"64","author":"Troncoso","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/NEN.0000000000000052","article-title":"Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent beta-amyloid and tau loads with divergent cognitive outcomes","volume":"73","author":"Iacono","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.medj.2025.100724_bib42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1515\/cclm.2002.197","article-title":"TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E","volume":"40","author":"Koch","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.medj.2025.100724_bib43","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.medj.2025.100724_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.medj.2025.100724_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103837","article-title":"Comparing tau status determined via plasma pTau181, pTau231 and [(18)F]MK6240 tau-PET","volume":"76","author":"Tissot","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.medj.2025.100724_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.14283\/jpad.2018.41","article-title":"Plasma Abeta42\/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study","volume":"6","author":"Perez-Grijalba","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.medj.2025.100724_bib47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100724_bib49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.medj.2025.100724_bib50","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.medj.2025.100724_bib51","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.medj.2025.100724_bib52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025001515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:24:19Z","timestamp":1758133459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025001515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666634025001515"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100724","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal progression of blood biomarkers reveals a key role of reactive astrocytosis in preclinical Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100724"}}